Role of survival post-progression in phase III trials of systemic chemotherapy in advanced non-small-cell lung cancer: a systematic review.

Role of survival post-progression in phase III trials of systemic chemotherapy in advanced non-small-cell lung cancer: a systematic review.

BACKGROUND: In advanced non-small-cell lung cancer (NSCLC), with the increasing number of active compounds available in salvage settings, survival after progression to first-line chemotherapy seems to have improved. A literature survey was conducted to examine whether survival post-progression (SPP)...

Full description

Bibliographic Details
Main Authors:	Katsuyuki Hotta, Katsuyuki Kiura, Yoshiro Fujiwara, Nagio Takigawa, Akiko Hisamoto, Eiki Ichihara, Masahiro Tabata, Mitsune Tanimoto
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2011-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3219633?pdf=render

Similar Items

Treatment-related death in patients with small-cell lung cancer in phase III trials over the last two decades.
by: Nobuaki Ochi, et al.
Published: (2012-01-01)

Twenty-seven years of phase III trials for patients with extensive disease small-cell lung cancer: disappointing results.
by: Isao Oze, et al.
Published: (2009-01-01)

Rapid on-site evaluation with BIOEVALUATOR® during endobronchial ultrasound-guided transbronchial needle aspiration for diagnosing pulmonary and mediastinal diseases
by: Daisuke Minami, et al.
Published: (2014-01-01)

Magnitude of the benefit of progression-free survival as a potential surrogate marker in phase 3 trials assessing targeted agents in molecularly selected patients with advanced non-small cell lung cancer: systematic review.
by: Katsuyuki Hotta, et al.
Published: (2015-01-01)

The Role of STAT3 in Non-Small Cell Lung Cancer
by: Daijiro Harada, et al.
Published: (2014-03-01)

Mechanisms of Acquired Resistance to ALK Inhibitors and the Rationale for Treating ALK-positive Lung Cancer
by: Hideko Isozaki, et al.
Published: (2015-04-01)

Whole blood interferon-gamma assay for baseline tuberculosis screening among Japanese healthcare students.
by: Katsuyuki Hotta, et al.
Published: (2007-01-01)

Crizotinib for recurring non‐small‐cell lung cancer with EML4‐ALK fusion genes previously treated with alectinib: A phase II trial
by: Daijiro Harada, et al.
Published: (2021-03-01)

Sarcopenia is associated with poor prognosis after chemoradiotherapy in patients with stage III non-small-cell lung cancer: a retrospective analysis
by: Kuniaki Katsui, et al.
Published: (2021-06-01)

Publisher Correction: Sarcopenia is associated with poor prognosis after chemoradiotherapy in patients with stage III non-small-cell lung cancer: a retrospective analysis
by: Kuniaki Katsui, et al.
Published: (2021-07-01)

Obstructive jaundice at the initial presentation in small-cell lung cancer
by: Nobuaki Ochi, et al.
Published: (2010-02-01)

Efficacy of multimodal treatment for leptomeningeal metastases in a lung cancer harboring an EGFR mutation
by: Morichika D, et al.
Published: (2016-03-01)

Docetaxel for non small cell lung cancer harboring the activated EGFR mutation with T790M at initial presentation
by: Yamane H, et al.
Published: (2013-03-01)

Consolidation chemotherapy improves progression-free survival in stage III small-cell lung cancer following concurrent chemoradiotherapy: a retrospective study
by: Chen XR, et al.
Published: (2016-09-01)

Microwave ablation combined with chemotherapy improved progression free survival of IV stage lung adenocarcinoma patients compared with chemotherapy alone
by: Chunhai Li, et al.
Published: (2019-07-01)

A retinoid X receptor partial agonist attenuates pulmonary emphysema and airway inflammation
by: Daisuke Morichika, et al.
Published: (2019-01-01)

Lung stereotactic body radiation therapy for elderly patients aged ≥ 80 years with pathologically proven early-stage non-small cell lung cancer: a retrospective cohort study
by: Kenta Watanabe, et al.
Published: (2021-02-01)

Novel prospective umbrella‐type lung cancer registry study for clarifying clinical practice patterns: CS‐Lung‐003 study protocol
by: Kazuya Nishii, et al.
Published: (2021-03-01)

Survival Outcomes with Photodynamic Therapy, Chemotherapy and Radiation in Patients with Stage III or Stage IV Non-Small Cell Lung Cancer
by: Sumedha Chhatre, et al.
Published: (2021-02-01)

Chemotherapy plus atezolizumab for a patient with small cell lung cancer undergoing haemodialysis: a case report and review of literature
by: Mihoko Imaji, et al.
Published: (2021-05-01)

Evaluating Survival Outcome for Chemotherapy in Advanced Lung Cancer Patients
by: Pei-Yi Lin, et al.
Published: (2013)

MEASUREMENT OF ACOUSTICAL NOISES IN KD60 OVERSNOW VEHICLES OF THE 10TH JAPANESE ANTARCTIC RESEARCH EXPEDITION
by: Takeo YOSHINO, et al.
Published: (1970-08-01)

Radiation pneumonitis after definitive concurrent chemoradiotherapy with cisplatin/docetaxel for non‐small cell lung cancer: Analysis of dose‐volume parameters
by: Kuniaki Katsui, et al.
Published: (2020-07-01)

Impacts of post‐radiotherapy lymphocyte count on progression‐free and overall survival in patients with stage III lung cancer
by: Juliana Matiello, et al.
Published: (2020-11-01)

Dose-volume parameters predict radiation pneumonitis after induction chemoradiotherapy followed by surgery for non-small cell lung cancer: a retrospective analysis
by: Kuniaki Katsui, et al.
Published: (2019-11-01)

Progression-free survival, post-progression survival, and tumor response as surrogate markers for overall survival in patients with extensive small cell lung cancer
by: Hisao Imai, et al.
Published: (2015-01-01)

Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setouchi Lung Cancer Group Study 1301
by: Norihito Okumura, et al.
Published: (2021-05-01)

Survival of an elderly patient with lung cancer treated with first-line chemotherapy
by: Oscar Augusto Quintana Blancos, et al.
Published: (2021-10-01)

The effect on survival of continuing chemotherapy to near death
by: Ayanian John Z, et al.
Published: (2011-09-01)

Research Progress of Nutrition Support for Patients with Lung Cancer  During Chemotherapy
by: Yiqiao LUO, et al.
Published: (2014-12-01)

The study progress of second-line chemotherapy of small cell lung cancer
by: Qian MIAO, et al.
Published: (2008-08-01)

Cisplatin-induced hyponatremia in malignancy: comparison between brand-name and generic formulation
by: Ochi N, et al.
Published: (2014-12-01)

Endogenous Antiangiogenic Factors in Chronic Kidney Disease: Potential Biomarkers of Progression
by: Katsuyuki Tanabe, et al.
Published: (2018-06-01)

Mutational Profile Evaluates Response and Survival to First‐Line Chemotherapy in Lung Cancer
by: Yayi He, et al.
Published: (2021-02-01)

Small-cell lung cancer in England: trends in survival and chemotherapy using the National Lung Cancer Audit.
by: Aamir Khakwani, et al.
Published: (2014-01-01)

Cholesterol Effect on Survival and Development of Larval Mud Crab Scylla serrata
by: KATSUYUKI HAMASAKI, et al.
Published: (2012-03-01)

Cholesterol Effect on Survival and Development of Larval Mud Crab Scylla serrata
by: MUHAMMAD AGUS SUPRAYUDI, et al.
Published: (2012-03-01)

Perioperative chemotherapy of stage Ⅲ N2 non-small cell lung cancer
by: Shun LU, et al.
Published: (2008-10-01)

Chemotherapy on nonresectable stage Ⅲ N2 non-small cell lung cancer
by: Li ZHANG
Published: (2008-10-01)

Phospholipids Effect on Survival and Molting Synchronicity of Larvae Mud Crab Scylla serrata
by: MUHAMMAD AGUS SUPRAYUDI, et al.
Published: (2012-12-01)